DCTS

Clario Extends Leadership in Real-World Data Collection through New Partnership with ActiGraph, a Leading Activity Tracking and Wearable Tech Company

Retrieved on: 
Thursday, June 16, 2022
Quality of life, Time, Sleep, Medical imaging, Solution, DCTS, Industry, Centerpoint, FDA, Obesity, Gold standard, Cardiovascular disease, Science, Guest appearance, Technology, Neuroscience, CEO, Efficiency, High-integrity pressure protection system, Actigraphy, Clinical trial, PRO, Partnership, Patient, DCT, Gold, Motion, Lifestyle (sociology), Diabetes

PHILADELPHIA, June 16, 2022 /PRNewswire/ -- Clario, a technology company that delivers the leading endpoint solutions for decentralized (DCT), hybrid and site-based clinical trials, today announced that it is partnering with ActiGraph, a pioneer and leading provider of activity-sensing wearable technology, to further expand its already broad evidence generation platform and portfolio of decentralization technologies. The partnership will help clinical trial sites and sponsors drive efficiency and accuracy while increasing convenience for study participants. Clario will offer ActiGraph technologies to its customers in addition to its suite of eCOA, Precision Motion, Cardiac Safety, Respiratory, Medical Imaging and Trial Enablement solutions.

Key Points: 
  • The partnership will help clinical trial sites and sponsors drive efficiency and accuracy while increasing convenience for study participants.
  • In contrast, ActiGraph's FDA-cleared, medical-grade platform captures objective, real-world biometric data related to physical activity, mobility, sedentary behavior and sleep.
  • Founded in 2004, ActiGraph is a leading wearable technology partner within the pharmaceutical and academic life science research industries.
  • Clario is a leading technology company that generates the richest clinical evidence in the industry for our pharmaceutical, biotech and medical device partners.

Medidata Leaders to Share Best Practices on Decentralized Trials, Patient Centricity, and Adaptive Trial Design at DIA Annual Meeting

Retrieved on: 
Wednesday, June 15, 2022
Data Management, Biotechnology, Technology, Health, General Health, Pharmaceutical, Other Science, Other Technology, Research, Science, Clinical Trials, Population, Learning, Map, Participation, COVID-19, Product management, Efficiency, Empathy, Euronext Paris, Adoption, Future, CATIA, Clinical trial, Transformation, SOLIDWORKS, 3D, Financial management, Dassault Group, Patient, SIMULIA, DIA, Communication, Diamond, DELMIA, Risk, Pharmaceutical industry, Creative industries, DCTS, ENOVIA, Research, Medidata Solutions, GEOVIA, Compass, BIOVIA

Medidata experts will also be participating in multiple presentations and panels covering a range of innovative solutions to advance clinical trial planning, management, and operations.

Key Points: 
  • Medidata experts will also be participating in multiple presentations and panels covering a range of innovative solutions to advance clinical trial planning, management, and operations.
  • The patient focus and collaborative environment of the DIA Annual Meeting is more important than ever, as we use decentralized trials to bring opportunities to more diverse groups and focus on patient needs, said Jackie Kent, chief customer officer at Medidata.
  • Participants will learn some of the foundational elements of designing decentralized clinical trials/hybrid trials, and how these advancements in trial design impact all of the stakeholders involved including the patient, sponsor, and site.
  • The session will cover the process from protocol design to interim analysis and communication to key stakeholders for adaptations.

Bezyl's digital health app aims to support the mental health of patients by bringing the power of each patient's network to the palm of the hand

Retrieved on: 
Tuesday, May 31, 2022
Tea, Family, Guest appearance, Patient, Frost & Sullivan, Caregiver, Clinical trial, DCTS, Cros, Partnership, Compliance, Anxiety, Technology, Reading, Cancer, Mental health, Friends, JLL Partners, CEO, Pharmaceutical industry, Medicine, Video game

Grounded within a secure communications platform, the Bezyl app makes it easier for patients to ask for help from friends, family, and caregivers.

Key Points: 
  • Grounded within a secure communications platform, the Bezyl app makes it easier for patients to ask for help from friends, family, and caregivers.
  • With the Bezyl app, patients can easily request help from their network, set check-ins and reminders, and track their moods.
  • As a peer-support tool, the Bezyl app aims to help patients eliminate anxiety, retain their participation in clinical trials, maintain treatment compliance, and most importantly, build their mental strength.
  • "We are proud to offer Bezyl to our customers as a secure and unique solution to support mental health."

Thermo Fisher Scientific’s Clinical Research Business Named a Leader in Decentralized Clinical Trial Solutions by ISG

Retrieved on: 
Thursday, May 12, 2022
General Health, Health, Science, Research, Clinical Trials, Thermo Fisher Scientific, Traction, Applied Biosystems, Science, Patient, Investment, Patheon, PPD, Solution, Health, ISG, Clinical trial, Nursing, COVID-19, Research, Fisher Scientific, Industry, DCTS, Telehealth, Matrix, Technology, Invitrogen, Mindful Scientific Inc., Laboratory, Pharmaceutical Services Negotiating Committee, Fine chemical, Pharmaceutical industry

The PPD clinical research business of Thermo Fisher Scientific, the world leader in serving science, has been distinguished for industry leadership in digital and decentralized clinical trial solutions by Information Services Group (ISG), a leading global technology research and advisory firm.

Key Points: 
  • The PPD clinical research business of Thermo Fisher Scientific, the world leader in serving science, has been distinguished for industry leadership in digital and decentralized clinical trial solutions by Information Services Group (ISG), a leading global technology research and advisory firm.
  • The business was recognized as an ISG Provider Lens Leader for its digital transformation services, including customer solutions for clinical development and patient engagement.
  • In its 2021 ISG Provider Lens Life Sciences Digital Services Global Report , ISG recognized Thermo Fishers clinical research business with a clinical development leader designation for its skill and dexterity in implementing digital clinical trials, combined with deep domain expertise and a reputation for innovation.
  • ISG also conferred its patient engagement leader acknowledgement on the business for its comprehensive suite of solutions that support interactions with patients participating in clinical studies.

Science 37® Extends Leadership in Decentralized Clinical Trial Market with NextGen SaaS Release to Fully Orchestrate Decentralized Study Conduct

Retrieved on: 
Tuesday, May 10, 2022
Ingelheim am Rhein, IDC, Population, Automation, Senior, GLOBE, Clinical research, Science 37, Science, Patient, Partnership, Thermo Fisher Scientific, Clinical trial, RESEARCH, Boehringer Ingelheim, Industry, Compliance, List of life sciences, Guest appearance, PARK, Cros, Software as a service, Technology, DCTS, Pharmaceutical industry, Cryptocurrency

Unlike many point solutions that enable components of decentralization, the Science 37 technology platform delivers the most comprehensive end-to-end solution in the industry.

Key Points: 
  • Unlike many point solutions that enable components of decentralization, the Science 37 technology platform delivers the most comprehensive end-to-end solution in the industry.
  • Purpose-built to fully orchestrate study conduct across all clinical trial stakeholders, Science 37s platform coordinates and unifies the stakeholder journey through every clinical trial visit, with exceptional data-capture features to increase compliance and generate the highest-quality data.
  • Science 37 has strengthened its SaaS platform with advanced configuration features for visit plans and forms with its newest release.
  • Technology platform features are available as full-service, self-service (SaaS), or self-service with support from Science 37.

Empowering Clinical Trial Sites to Deliver Better Clinical Data, Faster: Upcoming Webinar Hosted by Xtalks

Retrieved on: 
Tuesday, April 26, 2022
Adoption, Clinical trial, Oxford Vaccine Group, Imperial College London, Research, Clinical data management, ICT, ESourcing Capability Model, Patient, HIPAA, Lightning, Health information management, ICTU, Food, Openclinica, Technology, Millennium, Laika (EHR testing framework), University of Oxford, Title 21 CFR Part 11, Industry, University, DCTS, GDPR, Government, MPH, Pharmaceutical industry, Medical imaging, Medicine, Doctor of Philosophy

TORONTO, April 26, 2022 /PRNewswire-PRWeb/ -- With the clinical research space evolving at lightning speed, clinical trial sponsors and research sites may be overwhelmed when trying to scale and accelerate their trials to collect clinical data quickly and accurately. Enter technology.

Key Points: 
  • Attendees will learn methodologies for technology adoption among sites (clinical research coordinators, clinical data managers, monitors, and biostatisticians) that help reduce burnout.
  • TORONTO, April 26, 2022 /PRNewswire-PRWeb/ -- With the clinical research space evolving at lightning speed, clinical trial sponsors and research sites may be overwhelmed when trying to scale and accelerate their trials to collect clinical data quickly and accurately.
  • In this webinar, a panel of clinical trial experts come together to discuss the role that technology plays in clinical data capture.
  • For more information, or to register for this event, visit Empowering Clinical Trial Sites to Deliver Better Clinical Data, Faster.

Medical Research Network Are Announced Winners of a Queen’s Award for Enterprise: International Trade 2022

Retrieved on: 
Thursday, April 21, 2022
Technology, Research, Clinical Trials, Software, Biotechnology, Health, Pharmaceutical, Data Management, Science, CEO, Clinical trial, Achievement, Research, DCT, Patient, COO, Growth, Efficiency, Enterprise, International trade, Environment, Digital technology, Solution, MRN, DCTS, Pharmaceutical industry

MRN, a leading Clinical Trial Support Organization, has been honored with a Queens Award for Enterprise for International Trade.

Key Points: 
  • MRN, a leading Clinical Trial Support Organization, has been honored with a Queens Award for Enterprise for International Trade.
  • Their Home Trial Support service takes clinical trial research visits to patients in their own community, wherever they live around the world.
  • Now in its 56th year, The Queens Awards for Enterprise are the most prestigious business awards in the UK.
  • The awards were first established in 1965 and are determined by panels of experts with very stringent success criteria.

THREAD Acquires CureClick, Optimizing the Pathway from Clinical Trial Awareness to Access

Retrieved on: 
Tuesday, April 19, 2022
CEO, Awareness, Clinical trial, Patient experience, Research, Caregiver, DCT, Patient, Frost & Sullivan, Technology, JLL Partners, Multimedia, DCTS, Guest appearance, Cros, Medicine, Pharmaceutical industry

CARY, N.C., April 19, 2022 /PRNewswire/ -- THREAD®, a leading technology and consulting service provider enabling electronic clinical outcome assessments (eCOA) and decentralized clinical trials (DCTs), today announced that it has acquired CureClick. Headquartered in Costa Mesa, Calif., CureClick offers the world's first proprietary crowdsourcing platform designed exclusively to accelerate awareness and participation in clinical research. CureClick follows THREAD's recent acquisitions of Modus Outcomes and inVibe, positioning THREAD as the industry's leading patient-centric provider of DCTs.

Key Points: 
  • Headquartered in Costa Mesa, Calif., CureClick offers the world's first proprietary crowdsourcing platform designed exclusively to accelerate awareness and participation in clinical research.
  • CureClick follows THREAD's recent acquisitions of Modus Outcomes and inVibe , positioning THREAD as the industry's leading patient-centric provider of DCTs.
  • This new scaled marketplace will operate as a feature of THREAD's industry-leading DCT platform to further automate and streamline the pathway from clinical trial education to enrollment for global DCTs.
  • THREAD is the industry-leading decentralized clinical trials technology and consulting service provider, helping biopharma and CROs decentralize clinical research and enable electronic clinical outcome assessments (eCOA) for sites, participants, caregivers and home health professionals.

Medidata Wins Citeline Awards for myMedidata, the Most Comprehensive Patient Portal for Decentralized Clinical Trials, and its Holistic Digital Oversight Solution to Enable Clinical Monitoring Strategies

Retrieved on: 
Monday, April 11, 2022
Data Management, Biotechnology, Technology, Health, General Health, Pharmaceutical, Research, Networks, Internet, Science, Clinical Trials, Risk, Electronic data capture, DCTS, Dassault Group, DELMIA, 3D, Clinical trial, Euronext Paris, Research, Risk management, CATIA, Maine Learning Technology Initiative, Learning, Electronic data, Technology, CTMS, Digital, SOLIDWORKS, SIMULIA, Movement, Patient, Pharmaceutical industry, ENOVIA, BIOVIA, Compass, Medidata Solutions, GEOVIA

Best Sponsor-Facing Technology Initiative for Medidatas Digital Oversight Solution , which facilitates clinical trial data oversight and monitoring, improving timelines, cost, and quality in the execution of decentralized clinical trials (DCTs).

Key Points: 
  • Best Sponsor-Facing Technology Initiative for Medidatas Digital Oversight Solution , which facilitates clinical trial data oversight and monitoring, improving timelines, cost, and quality in the execution of decentralized clinical trials (DCTs).
  • Medidata was presented with the awards in a ceremony held on April 7 in Boston.
  • Medidatas Digital Oversight Solution has a unique position in the market, unifying risk management, centralized monitoring, and a robust clinical trial management system (CTMS) on one platform.
  • As the first company to leverage digital health technologies for DCTs, we are proud to have received the Citeline Awards for myMedidata and Medidatas Digital Oversight Solution.

THREAD and Amazon Web Services Modernize Clinical Research with Launch of Cloud-based, AI-driven Decentralized Clinical Trials Technology

Retrieved on: 
Tuesday, March 29, 2022
DCTS, Guest appearance, CARY, DCT, Automation, Multimedia, Caregiver, Cros, Health care, SDV, Research, AI, Precision medicine, CEO, Technology, Machine learning, Amazon Web Services, Architecture, List of life sciences, AWS, Clinical trial, Frost & Sullivan, JLL Partners, Patient, Medical device

CARY, N.C., March 29, 2022 /PRNewswire/ -- THREAD®, the leading technology and consulting service provider enabling electronic clinical outcome assessments (eCOA) and decentralized clinical trials (DCTs), announced today that it is collaborating with Amazon Web Services, Inc. (AWS) to launch enhancements to the THREAD platform powered by enterprise-scale automation and built-in AI-driven technologies. These next-generation DCT technology features will serve as the backbone for modern clinical research by enabling faster, more efficient clinical trials while improving access for research participants with higher quality data capture across the life cycle of a study.

Key Points: 
  • THREAD is working with AWS Professional Services experts to design an advanced machine learning architecture and industry-leading AI models to automate processes for customers.
  • THREAD's new cloud-enabled platform features will accelerate clinical research by reducing inefficiencies in real-time data capture, auto-populating data workflows that are completed manually today and more.
  • "Our technology innovations are revolutionizing today's clinical research by helping our customers to design, operate, and scale modern clinical trial approaches," said John Reites, CEO, THREAD.
  • THREAD is the industry-leading decentralized clinical trials technology and consulting service provider, helping biopharma and CROs decentralize clinical research and enable electronic clinical outcome assessments (eCOA) for sites, participants, caregivers, and home health professionals.